Literature DB >> 17921453

Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias.

Jianmin Xiao1, Xixi Tian, Peter P Jones, Jeff Bolstad, Huihui Kong, Ruiwu Wang, Lin Zhang, Henry J Duff, Anne M Gillis, Sidney Fleischer, Michael Kotlikoff, Julio A Copello, S R Wayne Chen.   

Abstract

The 12.6-kDa FK506-binding protein (FKBP12.6) is considered to be a key regulator of the cardiac ryanodine receptor (RyR2), but its precise role in RyR2 function is complex and controversial. In the present study we investigated the impact of FKBP12.6 removal on the properties of the RyR2 channel and the propensity for spontaneous Ca(2+) release and the occurrence of ventricular arrhythmias. Single channel recordings in lipid bilayers showed that FK506 treatment of recombinant RyR2 co-expressed with or without FKBP12.6 or native canine RyR2 did not induce long-lived subconductance states. [(3)H]Ryanodine binding studies revealed that coexpression with or without FKBP12.6 or treatment with or without FK506 did not alter the sensitivity of RyR2 to activation by Ca(2+) or caffeine. Furthermore, single cell Ca(2+) imaging analyses demonstrated that HEK293 cells co-expressing RyR2 and FKBP12.6 or expressing RyR2 alone displayed the same propensity for spontaneous Ca(2+) release or store overload-induced Ca(2+) release (SOICR). FK506 increased the amplitude and decreased the frequency of SOICR in HEK293 cells expressing RyR2 with or without FKBP12.6, indicating that the action of FK506 on SOICR is independent of FKBP12.6. As with recombinant RyR2, the conductance and ligand-gating properties of single RyR2 channels from FKBP12.6-null mice were indistinguishable from those of single wild type channels. Moreover, FKBP12.6-null mice did not exhibit enhanced susceptibility to stress-induced ventricular arrhythmias, in contrast to previous reports. Collectively, our results demonstrate that the loss of FKBP12.6 has no significant effect on the conduction and activation of RyR2 or the propensity for spontaneous Ca(2+) release and stress-induced ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17921453      PMCID: PMC2760432          DOI: 10.1074/jbc.M707423200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Cardiac excitation-contraction coupling.

Authors:  Donald M Bers
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

2.  Lack of effect of cADP-ribose and NAADP on the activity of skeletal muscle and heart ryanodine receptors.

Authors:  J A Copello; Y Qi; L H Jeyakumar; E Ogunbunmi; S Fleischer
Journal:  Cell Calcium       Date:  2001-10       Impact factor: 6.817

3.  Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

Authors:  Hong-Bo Xin; Takaaki Senbonmatsu; Dong-Sheng Cheng; Yong-Xiao Wang; Julio A Copello; Guang-Ju Ji; Mei Lin Collier; Ke-Yu Deng; Loice H Jeyakumar; Mark A Magnuson; Tadashi Inagami; Michael I Kotlikoff; Sidney Fleischer
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

4.  FK506 does not affect cardiac contractility and adrenergic response in vitro.

Authors:  H Milting; P M Janssen; T Wangemann; H Kögler; E Domeier; T Seidler; K Hakim; M Grapow; O Zeitz; J Prestle; H R Zerkowski
Journal:  Eur J Pharmacol       Date:  2001-11-02       Impact factor: 4.432

5.  Altered interaction of FKBP12.6 with ryanodine receptor as a cause of abnormal Ca(2+) release in heart failure.

Authors:  K Ono; M Yano; T Ohkusa; M Kohno; T Hisaoka; T Tanigawa; S Kobayashi; M Kohno; M Matsuzaki
Journal:  Cardiovasc Res       Date:  2000-11       Impact factor: 10.787

6.  Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure.

Authors:  Ming Tao Jiang; Andrew J Lokuta; Emily F Farrell; Matthew R Wolff; Robert A Haworth; Héctor H Valdivia
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

Review 7.  Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Uwais Mohamed; Carlo Napolitano; Silvia G Priori
Journal:  J Cardiovasc Electrophysiol       Date:  2007-07

8.  FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure.

Authors:  Masafumi Yano; Shigeki Kobayashi; Masateru Kohno; Masahiro Doi; Takahiro Tokuhisa; Shinichi Okuda; Masae Suetsugu; Takayuki Hisaoka; Masakazu Obayashi; Tomoko Ohkusa; Michihiro Kohno; Masunori Matsuzaki
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

9.  Effects of FK506 on [Ca2+]i differ in mouse and rabbit ventricular myocytes.

Authors:  Zhi Su; Kazuro Sugishita; Fenghua Li; Michael Ritter; William H Barry
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

10.  Molecular basis of Ca(2)+ activation of the mouse cardiac Ca(2)+ release channel (ryanodine receptor).

Authors:  P Li; S R Chen
Journal:  J Gen Physiol       Date:  2001-07       Impact factor: 4.086

View more
  42 in total

Review 1.  Supramolecular assemblies and localized regulation of voltage-gated ion channels.

Authors:  Shuiping Dai; Duane D Hall; Johannes W Hell
Journal:  Physiol Rev       Date:  2009-04       Impact factor: 37.312

Review 2.  Calcium signaling in cardiac myocytes.

Authors:  Claire J Fearnley; H Llewelyn Roderick; Martin D Bootman
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

Review 3.  Role of ryanodine receptor subtypes in initiation and formation of calcium sparks in arterial smooth muscle: comparison with striated muscle.

Authors:  Kirill Essin; Maik Gollasch
Journal:  J Biomed Biotechnol       Date:  2009-12-08

Review 4.  FK506-binding proteins 12 and 12.6 (FKBPs) as regulators of cardiac Ryanodine Receptors: Insights from new functional and structural knowledge.

Authors:  Luis A Gonano; Peter P Jones
Journal:  Channels (Austin)       Date:  2017-06-21       Impact factor: 2.581

5.  Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Dawei Jiang; Peter P Jones; Darryl R Davis; Robert Gow; Martin S Green; David H Birnie; S R Wayne Chen; Michael H Gollob
Journal:  Channels (Austin)       Date:  2010-07-14       Impact factor: 2.581

6.  Sensitized signalling between L-type Ca2+ channels and ryanodine receptors in the absence or inhibition of FKBP12.6 in cardiomyocytes.

Authors:  Yan-Ting Zhao; Yun-Bo Guo; Lei Gu; Xue-Xin Fan; Hua-Qian Yang; Zheng Chen; Peng Zhou; Qi Yuan; Guang-Ju Ji; Shi-Qiang Wang
Journal:  Cardiovasc Res       Date:  2017-03-01       Impact factor: 10.787

7.  Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks.

Authors:  Tao Guo; Razvan L Cornea; Sabine Huke; Emmanuel Camors; Yi Yang; Eckard Picht; Bradley R Fruen; Donald M Bers
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

8.  Regulation by FK506 and rapamycin of Ca2+ release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR.

Authors:  D MacMillan; J G McCarron
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

Review 9.  Dysregulated sarcoplasmic reticulum calcium release: potential pharmacological target in cardiac disease.

Authors:  Sandor Györke; Cynthia Carnes
Journal:  Pharmacol Ther       Date:  2008-07-12       Impact factor: 12.310

Review 10.  Pharmacological characteristics and clinical applications of K201.

Authors:  Noboru Kaneko; Ryuko Matsuda; Yoshihito Hata; Ken Shimamoto
Journal:  Curr Clin Pharmacol       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.